美国食品和药物管理局批准使用定制免疫细胞的新型黑色素瘤治疗, FDA approves new melanoma therapy using tailored immune cells, showing promising results.

食品和药物管理局已经批准了一种新疗法 治疗高级黑瘤, 一种严重的皮肤癌。 The FDA has approved a new therapy for advanced melanoma, an aggressive skin cancer. 这种创新治疗方法使用病人的免疫细胞,专门用来攻击他们特定的癌症细胞,显示出55%的响应率,14%的病人完全癌症消失。 This innovative treatment uses a patient's immune cells, tailored to attack their specific cancer cells, showing a 55% response rate and complete cancer disappearance in 14% of patients. 这标志着在治疗乳腺瘤方面取得显著进步,目前正在研究如何在治疗乳腺瘤和其他癌症的早期阶段使用。 This marks a significant advancement in melanoma treatment and is being studied for use in earlier stages of melanoma and other cancers.